Musculoskeletal Imaging - Original Article

Hydroxyapatite deposition disease around the hip: outcomes of CT-guided treatment

10.5152/dir.2016.15616

  • Michail E. Klontzas
  • Evangelia E. Vassalou
  • Aristeidis H. Zibis
  • Apostolos H. Karantanas

Received Date: 24.12.2015 Accepted Date: 17.03.2016 Diagn Interv Radiol 2016;22(5):466-470

PURPOSE:

Hydroxyapatite deposition disease (HADD) around the hip joint is a self-limiting condition usually treated conservatively. The aim of the present study is to directly compare the outcomes of CT-guided and conservative treatments in cases of refractory hip HADD.

METHODS:

Two groups of patients with refractory hip HADD were prospectively constructed from a pool of 484 patients referred for greater trochanter pain syndrome, based on the presence of calcifications around the hip and the failure of conservative treatment. Study group included 22 hips, which underwent CT-guided barbotage and steroid injection treatment, whereas control group consisted of 28 hips that were treated conservatively. Evaluation of the outcome of both groups was performed over a one-year follow-up period with the use of a score measuring clinical improvement in terms of pain and functional impairment.

RESULTS:

Three weeks after the initiation of treatment, study group exhibited significantly higher scores compared with the control group (P < 0.001). Improvement scores of the control group were similar to the study group after three months of treatment (P > 0.1).

CONCLUSION:

CT-guided treatment provides relief of debilitating symptoms in the acute phase.